Terminated PHASE3 INTERVENTIONAL 2-arm NCT02903355

Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)

Sponsor: Southern Illinois University

Updated 12 times since 2017 Last updated: Jun 2, 2022 Started: Sep 30, 2013 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Southern Illinois University

See all terminations from Southern Illinois University

This PHASE3 trial investigates Noise-induced Hearing Loss and is currently terminated or withdrawn. Southern Illinois University leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE3
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE3
Jul 2022 — Dec 2022 [monthly]

Terminated PHASE3

▶ Show 7 earlier versions

Apr 2022 — Jul 2022 [monthly]

Terminated PHASE3
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE3
May 2019 — Jan 2021 [monthly]

Terminated PHASE3
Jun 2018 — May 2019 [monthly]

Terminated PHASE3
Jan 2018 — Jun 2018 [monthly]

Terminated PHASE3
Feb 2017 — Jan 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Southern Illinois University

Data source: Southern Illinois University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Jackson, United States